Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 44,058 | -8,627 | -2,431 | 3,191 | -421 |
| Depreciation Amortization | 1,026 | 5,278 | 2,945 | 2,026 | 1,014 |
| Income taxes - deferred | -2,432 | -3,618 | -2,533 | 1,119 | 902 |
| Accounts receivable | -89,710 | 9,529 | 5,343 | -1,981 | 5,810 |
| Accounts payable and accrued liabilities | -1,651 | 10,162 | 6,449 | 4,868 | 6,291 |
| Other Working Capital | -65,471 | 9,537 | 5,488 | 2,490 | 7,975 |
| Other Operating Activity | 97,569 | 5,958 | 4,877 | 7,358 | -11,093 |
| Operating Cash Flow | $-16,611 | $28,219 | $20,138 | $19,071 | $10,478 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -5,000 | -5,000 | -5,000 | -5,000 |
| PPE Investments | -168 | -323 | -274 | -269 | -384 |
| Investing Cash Flow | $-168 | $-5,323 | $-5,274 | $-5,269 | $-5,384 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,000 | -8,000 | -6,000 | N/A | N/A |
| Common Stock Issued | N/A | 2,398 | 1,841 | 1,608 | 1,963 |
| Common Stock Repurchased | -8,053 | -21,213 | -12,568 | -4,297 | -1,432 |
| Other Financing Activity | -1,305 | -1,577 | -1,551 | -5,551 | -3,551 |
| Financing Cash Flow | $-11,358 | $-28,392 | $-18,278 | $-8,240 | $-3,020 |
| Beginning Cash Position | 97,659 | 103,155 | 103,155 | 103,155 | 103,155 |
| End Cash Position | 69,522 | 97,659 | 99,741 | 108,717 | 105,229 |
| Net Cash Flow | $-28,137 | $-5,496 | $-3,414 | $5,562 | $2,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,611 | 28,219 | 20,138 | 19,071 | 10,478 |
| Capital Expenditure | -168 | -323 | -274 | -269 | -384 |
| Free Cash Flow | -16,779 | 27,896 | 19,864 | 18,802 | 10,094 |